Jon Stobo

Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial

Nicholas MacLeod, Anthony J. Chalmers, N. O’Rourke et al. · Journal of Thoracic Oncology · 2015 · 80 citations · Full text

Medicine, Oncology, Radiation Oncology +12

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

Gillian A. Horne, Jon Stobo, Caroline Kelly et al. · Leukemia · 2020 · 77 citations · Full text

Medicine, Hematology, Pharmacology +16

Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex

Min Chen, Paolo Gallipoli, Donna DeGeer et al. · JNCI Journal of the National Cancer Institute · 2013 · 73 citations · Full text

Medicine, Oncology, Pharmacology +13

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status

Ben Fulton, Susan Short, Allan James et al. · Clinical and Translational Radiation Oncology · 2017 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Phase II Study Investigating Pazopanib Versus Weekly Paclitaxel in Relapsed or Progressive Urothelial Cancer

Robert J. Jones, Syed A. Hussain, Andrew Protheroe et al. · Journal of Clinical Oncology · 2017 · 30 citations · Full text

Medicine, Oncology, Pharmacology +8